Ligand Pharmaceuticals Inc (LGND)
114.58
+0.64
(+0.56%)
USD |
NASDAQ |
Dec 20, 16:00
115.00
+0.42
(+0.37%)
After-Hours: 20:00
Ligand Pharmaceuticals Profit Margin (Quarterly): -13.84% for Sept. 30, 2024
Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| Cellectar Biosciences Inc | -- |
| Revance Therapeutics Inc | -63.65% |
| Pieris Pharmaceuticals Inc | -- |
| Zymeworks Inc | -186.6% |
| CNS Pharmaceuticals Inc | -- |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | 5.97% |
| Return on Assets | 5.27% |
| Return on Invested Capital | 5.97% |
| Gross Profit Margin (Quarterly) | 95.27% |
| Operating Margin (Quarterly) | 21.14% |
| Return on Net Operating Assets | 9.12% |